Navigation Links
Getting rid of unwanted visitors
Date:9/20/2013

The digestive systems of all animals contain a large number of different bacteria. Humans are no exception and our intestines provide warmth, shelter and food to a vast range of unicellular organisms, many of which are either beneficial to their hosts or at least cause no ill effects other than consuming some of the food we ingest. However, several species have been associated with disease. Among them is Helicobacter pylori, which may play a part in causing chronic gastritis and gastric ulcers.

An ancient colonizer recently discovered

Helicobacter pylori was only discovered about thirty years ago. Subsequent investigations have shown that it originated in Africa and has been associated with humans for at least 100,000 years. The first humans to be infected with the bacterium were San hunter-gatherers in southern Africa and the infection spread to Europe and Asia when humans left Africa and migrated north and east. Eventually, colonization of Australia and the Americas brought Helicobacter pylori into these continents. The bacterium is now found in about 50% of humans worldwide, making it the most widespread and prevalent infection in our species.

In view of the ancient nature of the association between Helicobacter pylori and man, it seems likely that the stomachs of other hunter-gatherer communities might also contain longstanding and distinct populations of the bacterium. This assumption has now been tested and shown to be incorrect by an international consortium coordinated by Yoshan Moodley of the Vetmeduni's Department of Integrative Biology.

Baka pygmies show a low incidence of Helicobacter infection

Gastric biopsies were taken from Baka pygmies and neighbouring agricultural communities in south-eastern Cameroon and sent to the Hannover Medical School in Germany for sequencing. The researchers found the expected high prevalence (over 80%) of Helicobacter pylori in the guts of non-Baka individuals, although only about 20% of the hunter-gatherer Baka pygmies were infected with the bacterium. Furthermore, the scientists were unable to detect any strains of Helicobacter pylori specific to the pygmies: the bacteria instead appeared to come from groups associated with Nilo-Saharan populations or with a new subpopulation that seemed to relate to the expansion of Bantu-speaking tribes.

Bacteria are lost from small populations

Valeria Montano in Moodley's lab in Vienna used a population demographic model to estimate the age of association between Baka and non-Baka Helicobacter populations, which she found to be as recent as two to four thousand years. Further simulations suggested that the pygmies could easily "lose" the bacterium from their guts because of the small population size of the Baka tribe, possibly combined with the relatively low life expectancy of individual tribe members. The Helicobacter now infecting Baka pygmies are thus not the descendants of an ancient bacterial population but instead come from repeated re-infections from the pygmies' non-Baka neighbours over the last few thousand years.

Moodley is naturally excited by the findings. "We had expected to find an ancient lineage of bacteria in the pygmies but instead showed that certain demographic factors such as small population size and unusually low life expectancy could lead to the natural eradication of the bacteria from human populations."


'/>"/>

Contact: Susanna Kautschitsch
susanna.kautschitsch@vetmeduni.ac.at
43-120-577-1153
University of Veterinary Medicine -- Vienna
Source:Eurekalert

Related biology news :

1. Strax Rejuvenation Releases a New Radio Ad that is Getting a Lot of Attention from Listeners
2. Getting to the core of Fukushima
3. Getting Rid of Facial Wrinkles and Toning Up in 2013
4. Getting to grips with migraine
5. Getting to the root of horseradish root problems
6. Getting under the shell of the turtle genome
7. School-based kitchen gardens are getting an A+
8. Cheating -- and getting away with it
9. Overweight pregnant women not getting proper weight-gain advice
10. Texas cotton getting a genetic tune-up
11. Getting (drugs) under your skin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: